Top in hem/onc: Sexual health of cancer survivors, genetic mutations in breast cancer

An in-depth look at the complexity of sexual well-being among cancer survivors was last week’s top story in hematology/oncology.

Other top stories include new data on genetic mutations and breast cancer risk in women and racial disparities in colorectal cancer.

Read these and more in hematology/oncology below:

Sexual health of cancer survivors a complex, often undiscussed topic

The topic of sexual health among cancer survivors, when addressed at all, tends to focus on concrete, treatable issues, such as fertility and erectile dysfunction. However, cancer survivors also face several other, less straightforward obstacles to intimacy and sexual well-being. Read more.

Several genetic mutations linked to breast cancer risk among women in general population

Certain genetic mutations in breast cancer predisposition genes could inform screening and improve management of women at low risk for the disease, according to results of two studies published in The New England Journal of Medicine. Read more.

Steady rise in early-onset colorectal cancer among Blacks calls for renewed outreach

Colorectal cancer is the third most diagnosed cancer in the U.S., with a 20% higher incidence among Black individuals compared with their white counterparts. Read more.

ASCO Annual Meeting shifts to all-virtual format

ASCO Annual Meeting once again will follow an all-virtual format. The society released a statement indicating the “online-only experience” will be held June 4-8. Read more.

Allogeneic CAR T-cell therapy safe, clinically active in metastatic colorectal cancer

An allogeneic chimeric antigen T-cell therapy showed evidence of clinical activity among patients with metastatic colorectal cancer, according to results of a dose-escalation study presented at Gastrointestinal Cancers Symposium. Read more.